Clinical Trial Update: Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial update comparing metformin to empagliflozin assessing efficacy and safety in slowing chronic kidney disease progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Empagliflozin (empagliflozin)
• metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Renal Insufficiency, Chronic | Phase 2, Phase 3 | Status: COMPLETED